The Targeted Drug Delivery Lab is primarily dedicated to using nano and polymer-technology to improve the delivery of chemotherapeutic drugs towards sites of tumour growth and metastasis, while limiting drug exposure throughout the rest of the body. In particular, her focus is on eliminating cancers that have spread to regional (sentinel) lymph nodes and the lungs with the view to maximise the successful treatment of metastatic cancers and improve survival rates for cancer patients.

Dr Kaminskas also has an interest in evaluating how nanoparticles and nanomedicines are cleared from healthy and diseased lungs after inhaled delivery and in understanding the fundamental basis for gender differences in the pharmacokinetics of macromolecular drugs and nanomedicines.